Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental work with anabolics in autoimmunity models.

A H Schuurs, H A Verheul, L P Schot

    Acta Endocrinologica. Supplementum
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Retention costs 3 molars].

    Nederlands tijdschrift voor tandheelkunde·2002
    Same author

    [Cutaneous and mucosal reactions to dental materials].

    Nederlands tijdschrift voor tandheelkunde·2002
    Same author

    [Syndromes and sequences].

    Nederlands tijdschrift voor tandheelkunde·2002
    Same author

    [Working with mercury: cause of infertility in women?].

    Nederlands tijdschrift voor tandheelkunde·2002
    Same author

    Tibolone: a compound with tissue specific inhibitory effects on sulfatase.

    Molecular and cellular endocrinology·2001
    Same author

    [Oral lichen planus, amalgam and other restorative materials].

    Nederlands tijdschrift voor tandheelkunde·2001
    Same journal

    Studies on parathyroidal function in relation to hormonal influences and dietetic conditions.

    Acta endocrinologica. Supplementum·2014
    Same journal

    Advance abstracts of papers. Scandinavian Society for the Study of Diabetes: 23rd annual meeting. May 5-7, 1988, Bergen.

    Acta endocrinologica. Supplementum·1988
    Same journal

    Program of plenary sessions and advance abstracts of short communications. 32. Symposium Deutsche Gesellschaft für Endokrinologie. Hamburg, February 17-20, 1988.

    Acta endocrinologica. Supplementum·1988
    Same journal

    The use of GnRH analogues in combination with exogenous gonadotropins in infertile women.

    Acta endocrinologica. Supplementum·1988
    Same journal

    Precocious and delayed sexual development in children.

    Acta endocrinologica. Supplementum·1988
    Same journal

    Pulsatile GnRH therapy for the induction of ovulation in hypogonadotropic hypogonadism.

    Acta endocrinologica. Supplementum·1988
    See all related articles

    Nandrolone decanoate showed promise in treating autoimmune diseases in animal models, inhibiting symptoms in lupus and thyroiditis. Further research is needed to confirm its efficacy in other conditions like myasthenia gravis.

    Area of Science:

    • Immunology
    • Endocrinology
    • Pharmacology

    Background:

    • Autoimmune diseases involve the immune system attacking the body's own tissues.
    • Anabolic-androgenic steroids, like nandrolone, have immunomodulatory effects.
    • Investigating therapeutic potential of nandrolone in autoimmune disease models is crucial.

    Purpose of the Study:

    • To evaluate the efficacy of 19-nortestosterone (nandrolone) and nandrolone decanoate in preclinical models of autoimmune diseases.
    • To assess the impact of nandrolone on disease progression and immune parameters in various spontaneous and induced autoimmune conditions.

    Main Methods:

    • Six distinct animal models of autoimmune disease were utilized, including NZB/NZW F1 mice, NZB mice, OS chickens, MRL lpr/lpr mice, BB rats, and rats with experimentally induced myasthenia gravis.

    Related Experiment Videos

  • Nandrolone decanoate was administered to assess its effects on disease development and immune function.
  • Ethylestrenol was also tested in an initial experiment.

    • Main Results:

    • Nandrolone decanoate demonstrated inhibitory effects on disease symptoms and immune deterioration in three of five spontaneous autoimmune models: NZB/W mice (lupus glomerulonephritis, Sjögren's disease-like syndrome), NZB mice (lupus glomerulonephritis, autoimmune hemolytic anemia), and OS chickens (thyroiditis).
    • No significant effects were observed in MRL lpr/lpr mice (lupus glomerulonephritis, lymphoproliferative disease) and BB rats (insulin-dependent diabetes mellitus).
    • Preliminary data suggests potential activity of nandrolone decanoate in experimental myasthenia gravis, requiring further investigation. Ethylestrenol also showed favorable effects in initial tests.

    Conclusions:

    • Nandrolone decanoate exhibits therapeutic potential in specific autoimmune conditions, notably lupus and thyroiditis, as evidenced by animal model studies.
    • The compound's efficacy varies across different autoimmune disease models, highlighting the need for targeted therapeutic strategies.
    • Further research is warranted to elucidate the mechanisms of action and confirm the therapeutic benefits of nandrolone decanoate in autoimmune diseases, including myasthenia gravis.